Vice President, Chief Physician, Professor.Graduated from Guangzhou Medical College in 1985 and pursued further studies at the Cancer Hospital of the Chinese Academy of Medical Sciences for one year in 1990.Participated multiple times in international cancer conferences and national cancer conferences;Participate in multiple collaborative groups on cancer across the country;Organized and hosted multiple academic conferences on gastrointestinal tumors within the province.

Proficient in integrating multiple modes of medical treatment including surgery, chemotherapy, radiation therapy, and biological therapy, as well as laparoscopic minimally invasive surgery. Leading the way in the province in performing low rectal cancer double anastomosis anal preservation surgery and laparoscopic gastrointestinal minimally invasive surgery;And it has taken the lead in carrying out multidisciplinary comprehensive treatment (MDT) for gastrointestinal tumors, and has developed accelerated rehabilitation surgery (ERAS) for gastrointestinal tumors.

The clinical study of 5-FU treatment for colorectal cancer with portal vein catheterization won the fourth prize of Hainan Province Science and Technology Progress Award;Hosted multiple medical research projects of the Hainan Provincial Department of Health and the Hainan Provincial Natural Science Foundation;Published over 40 papers in core journals both domestically and internationally.

At the same time, actively participating in public welfare activities, he was awarded the title of "Outstanding Medical Volunteer" by the Chinese Charity Federation in 2009 and the "Outstanding Contribution Award" in 2017.

An expert in minimally invasive laparoscopic surgery, Dr. Zhou was among the first in the province to perform sphincter-preserving double anastomosis surgery for low rectal cancer and to apply minimally invasive radical surgery for gastrointestinal tumors. He has extensive experience in multidisciplinary treatment (MDT) for gastrointestinal cancers and in Enhanced Recovery After Surgery (ERAS) protocols.

Comprehensive diagnosis and treatment of gastrointestinal tumors.

Current Appointment:

1. Editorial Board Member of Chinese Journal of Metastatic Tumors

Previous Appointments:

1. Director of the Chinese Anti-Cancer Association

2. Committee Member of the Professional Committee on Cancer Prevention and Control of Chinese Preventive Medicine Association

3. President of the Hainan Anti-Cancer Association

4. Committee Member of the Colorectal Cancer Group of the Surgical Society of Chinese Medical Association

5. Committee Member of the Parenteral and Enteral Nutrition Professional Committee of the Chinese Research Hospital Association

6. Committee Member of the Neuroendocrine Tumor Branch of China International Exchange and Promotive Association for Medical and Health Care

1. Huang Y、 Ye M 、 Wang C、 et al. Protective effect of CDDO-imidazolide against intestinal ischemia/reperfusion injury in mice[J]. European Journal of Inflammation, 2018, 16(6):205873921880268。

2. Huang Youqun, Wang Zhenfen, Zhou Weiping. Characteristics and Clinical Significance of Changes in IL - 6, TNF - α, and CRP Levels in Colorectal Cancer Patients [J]. Cancer Progress, 2018, 16(9):3.

3. Zhou Weiping. Clinical Analysis of 38 Cases of Colorectal Cancer with Liver Metastasis [J]. Hainan Medical Journal, 2004, 15(6):2.

4. Zhou Weiping, Yang Zuoheng, Wang Guoxiong. Misdiagnosis Analysis of Rectal Cancer [J]. Hainan Medical Journal, 1995, 04:267 - 268.

5. Zhou Weiping. Experience in the Treatment of Anastomotic Leakage after Dixon Operation for Rectal Cancer [J]. Hainan Medical Journal, 1992, 003(003):41 - 42.

6. Zhou Weiping, Liu Hai, Cai Guohao, et al. Clinical Study on the Impact of 5-Fu Regional Chemotherapy on Liver Metastasis after Colorectal Cancer Surgery [J]. China Tropical Medicine, 2002, 2(2):2.

7. Zhou Weiping, Liu Hai, Fu Yong. Clinical Analysis of 110 Cases of Primary Small Intestinal Tumors [J]. China Tropical Medicine, 2003, 3(6):2.